The aging of the population is one of most common phenomena in many countries, especially developed countries. With advancing age, people are more likely to develop CVD (cardiovascular disease) and cancer, the two leading causes of death. Free oxygen radicals increase levels of lipid peroxidation and damage DNA and other subcellular structures, contributing to the development of CVD and cancer (1-3). Therefore, extensive preclinical and observational studies have been conducted to evaluate the preventive effects of antioxidant vitamins and minerals against oxidative stress and oxidative injury-related chronic diseases (4-6).Vitamin E is well-known as the most important lipid soluble antioxidant (7). In animal models, a-tocopherol, the active form of antioxidant vitamin E, has been associated with reductions in atherosclerotic lesions, smooth muscle cell proliferation and platelet adherence and aggregation (8-10). On the other hand, it has been widely demonstrated that vitamin E and certain other agents such as vitamin C (ascorbic acid), b-carotene and selenium cooperatively reduce oxidative stress (5, 6, 11, 12). The antioxidant effects of vitamin E can be strengthened by vitamin C (5), b-carotene and selenium (11, 13), and vitamin E can play a biochemical role that is analogous to the role of zinc in stabilizing membrane structure and reducing peroxidative damage (14). Vitamin E acts as the primary antioxidant and the resulting vitamin E radical then reacts with vitamin C to regenerate vitamin E (15).However, meta-analyses evaluating the antioxidant effect of vitamin E have reported a disappointing effect on survival (16)(17)(18)(19)(20). Among these meta-studies, the most recent and systematic study was reported 9 y ago and demonstrated that low-dose vitamin E slightly but non-significantly decreased the mortality but high-dose vitamin E increased mortality (18). High dosage of vitamin E intake has been revealed to contribute to many clinical disorders (21), which is consistent with the increased mortality for high-dose vitamin E. Otherwise, another meta-study on vitamin E, which used the same inclusion criteria as Miller et al. (18) but adopted a different meta-analytic method, also got a disappointing result (22, 23). Such an effect could obscure the effect of vitamin E in studies without considering the dosage, which is seen in several reports (16, 17, 19, 20 Neither vitamin E intake alone nor combined with other agents is associated with a reduction in all-cause mortality. But a low dose (,400 IU/d) of vitamin E combined with other agents is correlated with a reduction in all-cause mortality, and vitamin E intake combined with other agents is correlated with a reduction in the mortality rate among individuals without probable or confirmed diseases.